The disease is mainly characterized by cartilage degeneration.

Morning stiffness often persists for more than one hour.

The disease can begin in young or middle-aged adults.

The condition conditions are more common in women than in men

The condition frequently causes symmetrical involvement of the joints

Subcutaneous nodules may develop as part of the disease.

Radiographs may show osteophyte formation and subchondral sclerosis.

The condition can show joint space narrowing on radiographs

Extra-articular manifestations such as lung or eye involvement may occur.

Disease-modifying antirheumatic drugs are essential for long-term management.

Nonsteroidal anti-inflammatory drugs are used mainly for symptomatic relief.

Blood tests are essential for confirming the diagnosis.

The cervical spine can be affected, sometimes leading to instability.

Joint deformities such as ulnar deviation may appear.

Fatigue, weight loss, and general malaise may accompany the disease.

The condition can lead to progressive joint pain and reduced mobility.

The condition can cause functional disability in advanced stages.

The condition may require surgical intervention such as joint replacement in severe cases.

Anti-CCP antibodies are frequently positive in this disease

Joint inflammation is typically more severe in this condition.

This condition can lead to systemic complications beyond the joints.

Bone erosion can be observed in advanced stages of this disease.

In this disease, the number of affected joints is counted to assess activity

This condition is typically assessed using the DAS28 score